<DOC>
	<DOC>NCT00225524</DOC>
	<brief_summary>Phase III long-term safety study of Effexor XR in patients with major depression.</brief_summary>
	<brief_title>Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Patients who complete the Phase III doubleblind study (Protocol Number 0600B1816) Patients with schizophrenia or any other psychotic disorder Patients with history or presence of bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Depression</keyword>
</DOC>